WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)

Clinical trial NCT07615894 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07615894
Sponsor: WestVac Biopharma Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Malignant Pleural Effusions Malignant Ascites

Start date: 2026-06-01
Primary completion: 2028-01-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.